Abnormal H3K4 enzyme catalytic activity and neuronal morphology caused by ASH1L mutations in individuals with Tourette syndrome.

Eur Child Adolesc Psychiatry

Department of Neurology, Linyi People's Hospital, 27 East Section of Jiefang Road Lanshan District, Linyi, 276000, Shandong, China.

Published: November 2024

AI Article Synopsis

  • * The study involved five TS families, where researchers validated ASH1L mutations and used various techniques to explore how these mutations affect neuronal growth and correlate with TS traits.
  • * Findings revealed that mutations near ASH1L's catalytic domain lead to mental health issues by destabilizing the protein's structure, reducing its activity, and impairing neurite growth; further studies are needed for broader insights into TS and ASH1L's role.

Article Abstract

ASH1L potentially contributes to Tourette syndrome (TS) and other neuropsychiatric disorders, as our previous studies have shown. It regulates essential developmental genes by counteracting polycomb-mediated transcriptional repression, which restricts chromatin accessibility at target genes. ASH1L is highly expressed in the adult brain, playing a crucial role in the early stage. However, it remains unclear how ASH1L mutations carried by patients with TS participate in regulating neuronal growth processes leading to TS traits. Five TS families recruited in our study underwent comprehensive physical examinations and questionnaires to record clinical phenotypes and environmental impact factors. We validated the variants via Sanger sequencing and constructed two mutants near the catalytic domain of ASH1L. We conducted molecular modeling, in vitro assays, and primary neuron cultures to find the role of ASH1L in neuronal development and its correlation with TS. In this study, we validated five pathogenic ASH1L rare variants and observed symptoms in patients with simple tics and behavioral comorbidities. Mutations near the catalytic domain of TS patients cause mental state abnormalities and disrupt ASH1L function by destabilizing its spatial conformation, leading to decreased activity of catalytic H3K4, thereby affecting the neurite growth. We need to conduct larger-scale studies on TS patients and perform additional neurological evaluations on mature neurons. We first reported the effects of ASH1L mutations in TS patients, including phenotypic heterogeneity, protein function, and neurological growth. This information contributes to understanding the neurodevelopmental pathogenesis of TS in patients with ASH1L mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00787-024-02437-3DOI Listing

Publication Analysis

Top Keywords

ash1l mutations
16
ash1l
10
tourette syndrome
8
catalytic domain
8
patients
6
mutations
5
abnormal h3k4
4
h3k4 enzyme
4
catalytic
4
enzyme catalytic
4

Similar Publications

Precise regulation of the chromatin environment through post-translational histone modification modulates transcription and controls brain development. Not surprisingly, mutations in a large number of histone-modifying enzymes underlie complex brain disorders. In particular, the histone methyltransferase ASH1L modifies histone marks linked to transcriptional activation and has been implicated in multiple neuropsychiatric disorders.

View Article and Find Full Text PDF
Article Synopsis
  • Congenital malformations of the female genital tract (CM-FGT) involve abnormal development of reproductive organs and can also affect other systems, with no identified genetic causes until now.
  • A comprehensive whole-genome sequencing study was conducted on 590 participants in China, discovering various genetic anomalies associated with CM-FGT, including novel variants and highlighting ASH1L as a key pathogenic gene.
  • The study's findings enhance the understanding of the genetic factors contributing to CM-FGT and suggest potential for prenatal screening based on the identified spatiotemporal gene expression patterns during early uterine development.
View Article and Find Full Text PDF

Background: Histone methyltransferase absent, small, or homeotic discs1-like () is composed of su(var)3-9, enhancer of zeste, trithorax (SET) domain, pleckstrin homology domain (PHD) domain, middle (MID) domain, and bromo adjacent homology (BAH) domain. The SET domain of is known to mediate mediate H3K36 dimethylation (H3K36me2) modification. However, the specific functions of the PHD-BAH domain remain largely unexplored.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored the use of next-generation sequencing (NGS) to identify genetic variants in 55 children with childhood epilepsy of unknown origins, ultimately diagnosing about 50.9% of the cases.* -
  • Researchers found variants in 22 different epilepsy-associated genes, with significant findings related to SCN1A, ALDH7A1, and KCNQ2, which could inform targeted therapies for some patients.* -
  • The discovery of novel genetic variants enhances the understanding of the genetic factors linked to childhood epilepsy and aims to improve diagnosis and treatment strategies globally.*
View Article and Find Full Text PDF

The histone methyltransferase ASH1L, first discovered for its role in transcription, has been shown to accelerate the removal of ultraviolet (UV) light-induced cyclobutane pyrimidine dimers (CPDs) by nucleotide excision repair. Previous reports demonstrated that CPD excision is most efficient at transcriptional regulatory elements, including enhancers, relative to other genomic sites. Therefore, we analyzed DNA damage maps in ASH1L-proficient and ASH1L-deficient cells to understand how ASH1L controls enhancer stability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!